← Leaderboards
Mark P Rubinstein
Medical University Of South Carolina
$2,818,767
Attributed
$4,737,709
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,737,709 · 3
By mechanism
R01$4,737,709 · 3
Top collaborators
- John M. Wrangle5 shared
- Ernest Ramsay Camp3 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- John M. Wrangle$2,019,783
- Philip H Howe$17,002,249
- Haizhen Wang$1,873,394
- Besim Ogretmen$19,638,711
- Dennis K Watson$3,433,120
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseMalignant NeoplasmsMediatingT-LymphocyteMouse ModelAgonistNatural Killer CellsTumorCd8b1 GeneInflammatoryCytokinePreclinical StudyBiological MarkersMelanomaOncologyPublishingInterferon Type IiCd8-Positive T-LymphocytesImmunotherapyInterleukin-15FutureBiologicalDoseImmune
Grant awards (11)
Defining the role of tumoral MHC Class I Expression in Mediating Colorectal Cancer Racial Disparities$628,469
R01 · FY2025 · CA · contact PI
Defining the role of tumoral MHC Class I Expression in Mediating Colorectal Cancer Racial Disparities$597,046
R01 · FY2024 · CA · contact PI
Defining the role of tumoral MHC Class I Expression in Mediating Colorectal Cancer Racial Disparities$642,846
R01 · FY2023 · CA · contact PI
Lymphocyte and inflammatory cytokine markers of response in the first-in-human combination of anti-PD-1 mAb and IL-15/IL-15Ra complexes and investigation of mediators of anti-tumor immune responses$389,857
R01 · FY2023 · CA
Lymphocyte and inflammatory cytokine markers of response in the first-in-human combination of anti-PD-1 mAb and IL-15/IL-15Ra complexes and investigation of mediators of anti-tumor immune responses$389,857
R01 · FY2022 · CA
Lymphocyte and inflammatory cytokine markers of response in the first-in-human combination of anti-PD-1 mAb and IL-15/IL-15Ra complexes and investigation of mediators of anti-tumor immune responses$397,814
R01 · FY2021 · CA
Lymphocyte and inflammatory cytokine markers of response in the first-in-human combination of anti-PD-1 mAb and IL-15/IL-15Ra complexes and investigation of mediators of anti-tumor immune responses$397,814
R01 · FY2020 · CA · contact PI
Lymphocyte and inflammatory cytokine markers of response in the first-in-human combination of anti-PD-1 mAb and IL-15/IL-15Ra complexes and investigation of mediators of anti-tumor immune responses$394,181
R01 · FY2019 · CA · contact PI
Maximizing Memory T Cell Responses by Matured Post Chemotherapy Dendritic Cells$296,881
R01 · FY2012 · CA · contact PI
Maximizing Memory T Cell Responses by Matured Post Chemotherapy Dendritic Cells$296,881
R01 · FY2011 · CA · contact PI
Maximizing Memory T Cell Responses by Matured Post Chemotherapy Dendritic Cells$306,063
R01 · FY2010 · CA · contact PI